RETRACTED: Ultrasound-guided transvaginal ovarian needle drilling (UTND) for treatment of polycystic ovary syndrome: a randomized controlled trial
article
OA: bronze
CC0
RETRACTED
Retraction notice. Marked retracted by OpenAlex; see publisher for the formal retraction notice.
AI-generated summary
This randomized controlled trial investigated ultrasound-guided transvaginal ovarian needle drilling (UTND) as a treatment for polycystic ovary syndrome.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo evaluate the outcome of ovarian needle drilling using transvaginal ultrasound guidance as an alternative to the traditional laparoscopic electrosurgical drilling for patients with polycystic ovary syndrome (PCOS).DesignA randomized controlled study.SettingUniversity teaching hospital and private practice setting.Patient(s)The study comprised 163 patients with clomiphene-resistant PCOS.Intervention(s)Patients were randomly allocated to either treatment with ultrasound-guided transvaginal needle ovarian drilling (UTND; n = 82) or laparoscopic electrosurgery ovarian drilling (n = 81).Main outcome measure(s)Hormonal changes (FSH, LH, T), ovulation and pregnancy.Result(s)There were no significant differences between the two groups with regard to body mass index, hormonal profiles, clinical manifestations, and ultrasound findings of PCOS. The duration of UTND was 15.3 +/- 5.61 minutes (10.5-22.3 minutes), while it was 25.6 +/- 8.2 minutes (20.3-38.1 minutes) in laparoscopic drilling, with a statistically significant difference between the two groups. There were no significant differences between the two groups with regard to resumption of normal menstruation, hirsutism, acne, ovulation, and pregnancy. UTND resulted in significant improvement in the ovulation, pregnancy, hirsutism, and acne. There were significant decreases in the serum LH and T levels but not in the FSH or LH/FSH levels after UTND as well.Conclusion(s)UTND can be adopted as an outpatient office procedure. The ease of scheduling, reduced costs, and rapid recovery suggest it as a first-line treatment for PCOS cases resistant to clomiphene citrate.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (25)
- W57359013 via openalex
- W117239984 via openalex
- W1554998192 via openalex
- W1965318069 via openalex
- W1992956594 via openalex
- W1998506244 via openalex
- W2013145479 via openalex
- W2042754363 via openalex
- W2048985984 via openalex
- W2058273911 via openalex
- W2072701990 via openalex
- W2140520357 via openalex
- W2144012934 via openalex
- W2146910785 via openalex
- W2198261718 via openalex
- W2239299188 via openalex
- W2343632145 via openalex
- W2412204379 via openalex
- W2416036337 via openalex
- W2416523738 via openalex
- W3125170327 via openalex
- W4246678383 via openalex
- W4256605237 via openalex
- W6662461895 via openalex
- W6689595315 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK